News

Nature13y
Endophthalmitis following open-globe injuries
Prophylaxis of endophthalmitis in high-risk open-globe injuries may include systemic broad-spectrum antibiotics, topical antibiotics, and intravitreal antibiotics to cover both Gram-positive and ...
The Globe and Mail14y
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025
May 06, 2025 (GLOBE ... vector-based gene therapy targeting the RPGR protein. The study aims to assess two dose levels of laru-zova for efficacy, safety and tolerability in the untreated eye ...
Morningstar1mon
Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models
FREEHOLD, N.J., May 14, 2025 (GLOBE NEWSWIRE ... endpoints in two pre-clinical animal models of the Company’s eye drop formulations (“CT2000”) for the treatment of both acute ocular ...